Echo IQ Secures FDA Approval for AI-powered Diagnostic Software for Severe Aortic Stenosis Echo IQ (ASX:EIQ), the developer of AI-driven medical software to support the diagnosis of heart structural illnesses, has been awarded 510(k) clearance by the US FDA for its EchoSolv software. The software aims to help in the early diagnosis of severe aortic stenosis. Read more: https://nextdigitalhealth.com/healthcare/cardiac-care/echo-iq-secures-fda-approval-for-ai-powered-diagnostic-software-for-severe-aortic-stenosis/ #HealthcareNews #healthcareinnovation #HealthcareTechnology #Ai #medicaldevice #SaaS #nextdigitalhealth #vineetagrawal #Wi4